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Disorders of Endocrine System
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WD40-repeat (WDR)-containing proteins constitute an evolutionarily conserved large protein family with a broad range of biologi-
cal functions. In human proteome, WDR makes up one of the most abundant protein-protein interaction domains. Members of the 
WDR protein family play important roles in nearly all major cellular signalling pathways. Mutations of WDR proteins have been as-
sociated with various human pathologies including neurological disorders, cancer, obesity, ciliopathies and endocrine disorders. This 
review provides an updated overview of the biological functions of WDR proteins and their mutations found in congenital disorders. 
We also highlight the significant role of WDR proteins in ciliopathies and endocrine disorders. The new insights may help develop 
therapeutic approaches targeting WDR motifs.
Keywords: WDR proteins; Ciliopathies; Congenital, hereditary, and neonatal diseases and abnormalities; Neuroendocrine; Kall-
mann syndrome
INTRODUCTION 
WD40-repeat (WDR) refers to a series of loosely conserved 
structural motifs comprised of approximately 40 amino acids, 
often terminating in tryptophan (W)-aspartic acid (D). WDR 
protein family is a large group of proteins commonly possessing 
the WDR motifs, that are involved in a wide range of important 
biological processes. Inherited or acquired defects in WDR pro-
teins result in numerous health problems including neurological 
diseases, ciliopathies, and cancers. In this review, we provide a 
unique overview and discussion on the molecular mechanisms 
and functions of WDR proteins, especially focusing on those 
that have been associated with human congenital disorders and 
endocrine diseases. Many of the WDR proteins are called differ-
ent names mainly due to historical reasons. The official gene 
nomenclature along with full and alternative names of WDR 
proteins (based on UniProt) discussed in this review are sum-
marised in the Supplemental Table S1. WDR proteins associated 
with pathological conditions that are not discussed in the main 
text in detail are summarised in the Supplemental Table S2.
MOLECULAR STRUCTURE OF WDR 
PROTEINS 
WDR motif was first described in the β-subunit of a GTP-bind-
ing protein transducin complex as a sequence of repeats of 40 to 
60 amino acids that begin with glycine and histidine (GH) and 
end with tryptophan and aspartic acid (WD) dipeptides [1]. 
WDR is an evolutionarily conserved and highly abundant do-
main in eukaryotes with nearly 1% of human proteomes con-
sisting of WDR-containing proteins [2]. Most recent protein do-
main database (SMART, http://smart.embl.de/) predicts that 921 
WDR proteins are encoded in humans, 591 in Mus musculus 
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and 212 in Drosophila melanogaster. WDR proteins are rarely 
present in prokaryotes [2]. Each WDR protein can have 4 to 16 
copies of WDRs forming seven or more bladed beta-propeller 
folds [3], which can provide three structural surfaces (top, side, 
and bottom region of propeller) available to interact with other 
binding partners [2]. Based on these structural features, it is sug-
gested that WDR proteins could serve as a scaffold that medi-
ates protein-protein or protein-DNA interaction [4]. Since 
WDRs do not possess any catalytic activity themselves, func-
tional diversity is likely achieved by coordination of multiple 
binding partners. Mutations in WDR proteins have been report-
ed in several human diseases. Notably, clinically identified mu-
tations of WDR are mostly found on the surface of the protein, 
presumably interfering their binding interactions with other pro-
teins [1,2,4]. 
BIOLOGICAL FUNCTIONS OF WDR 
PROTEINS
WDR proteins can be primarily defined by their sequence simi-
larity in the WD40-repeat domain. However, a wide range of 
sequence variation has been found in WD40-repeats, resulting 
in variable numbers of beta-propeller structures. Variations out-
side of the WD-repeat domain can also contribute to the multi-
domain contexts [5]. In fact, although all WDR proteins are 
structurally related, their molecular functions can be quite dis-
tinct. This functional diversity is usually acquired from the ad-
ditional domains present in the respective WDR proteins. Cur-
rently, more than 360 additional domains are reported in WDR 
proteins [6]. The most commonly found additional domains are 
shown to be functionally involved with ubiquitylation (e.g., F-
box [7], SOCS-box [8], RING-finger [9]), microtubule dynam-
ics (e.g., CTLH domain [10]), phospholipid-binding (e.g., 
FYVE domain [11]) and endocytic vesicle coating (e.g., clathrin 
terminal domain [12]). WDR domains are also identified in es-
sential subunits of multiprotein complexes that participate in 
various signalling pathways regulating DNA repair [13-15], 
protein degradation [16,17], cell cycle control [18,19], mRNA 
translation [20,21], cilia assembly and maintenance [22,23], and 
hormone biosynthesis [24]. Therefore, it is not surprising that 
WDR proteins play important roles in fundamental cellular 
functions, such as signal transduction, gene expression, RNA 
processing, protein synthesis, homeostasis, proliferation, apop-
tosis, intracellular vesicle trafficking, and cargo recognition 
[2,25-29]. 
WDR PROTEINS IN HUMAN DISEASE 
According to the Online Mendelian Inheritance in Man 
(OMIM) database (https://omim.org/), there is a significant cor-
relation between WDR protein dysfunction and human diseases 
(Fig. 1). Among 360 WDR genes we assessed, 79 genes were 
reported to be associated with human pathologies which include 
neurological disorders (40.5%), ciliopathies (21.5%), immune 
diseases (8.9%), eye problems (7.6%), skeletal anomalies 
(3.8%), cancers (3.8%), endocrine disorders (2.5%), inflamma-
tion (2.5%), and others including preimplantation embryonic le-
thality (8.9%). 
Notably, a significant number of WDR proteins have been as-
sociated with ciliopathies, a group of genetic disorders resulting 
from defects in the structure or function of cilia. Cilia are highly 
conserved microtubule-based hair-like organelles that extend 
from the plasma membrane of most vertebrate cells. Cilia can 
broadly be classified into two types, motile and non-motile (pri-
mary) cilia that share the principal axoneme structures [30,31]. 
The axoneme consists of a circular arrangement of nine pairs of 
microtubules called outer doublets. In addition to the outer dou-
blets, motile cilia contain a pair of microtubules in the centre 
called inner doublets [32]. This central pair of microtubules is 
the scaffold of the central pair complex including radial spokes, 
inner and outer dynein arms and nexin links [33]. The intrafla-
gellar transport (IFT) particles assemble and maintain the cilium 
by trafficking ciliary proteins within the cilium [22,23]. Two 
Fig. 1. A chart indicating the relevant prevalence of human diseases 
associated with WD40-repeat (WDR) proteins. The data are based 
on the entries in Online Mendelian Inheritance in Man (OMIM). 
Total 79 out of 360 WDR proteins have been linked with disease 
categories as indicated. The ‘others’ category includes multi-organ 
defects, liver failure, cardiovascular defects and embryonic lethali-
ty. The full list of WDR proteins assessed are included in Supple-
mentary Table  S1.
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subcomplexes IFT-A and IFT-B, consisting of at least 6 and 13 
proteins, respectively, move along the cilium bidirectionally via 
retrograde (IFT-A) and anterograde (IFT-B) transport. In retro-
grade transport (from the ciliary tip to the base), IFT-A uses dy-
nein-2 as a motor, whereas IFT-B is powered by kinesin-2 for 
anterograde movement [34,35]. Many IFT proteins contain pro-
tein-protein interaction motifs including WDRs, tetratricopep-
tide repeats and coiled coils motifs [22], facilitating the interac-
tion and transport of multiple cargos such as tubulin and dynein 
components [22,36,37]. Primary cilium serves as a regulatory 
platform and organising centre for many cellular signalling 
pathways [38] such as Hedgehog [39], receptor tyrosine kinases 
[40], and G protein-coupled receptors [41], playing critical roles 
in normal embryonic development and adult homeostasis [42]. 
Therefore, defects in the formation and function of primary cilia 
lead to a wide range of health problems [43], including renal 
dysfunction, retina degeneration, hypogonadism, diabetes, obe-
sity, hearing impairment, craniofacial/skeletal anomalies, car-
diovascular defects, and brain malformations [30,44-46], which 
are collectively termed as ciliopathies. 
WDR proteins associated with neurological disorders
Mutations of WDR proteins are most frequently associated with 
neurological disorders (see Table 1 for the full list). PAFAH1B1 
(LIS1) is the first WDR protein identified in severe brain mal-
formation called lissencephaly type 1 (also known as classic lis-
sencephaly) characterized by the absence or incomplete devel-
opment of the cerebral cortex, causing unusually smooth brain 
surface. Lissencephaly can occur in association with other syn-
dromes such as Miller-Dieker syndrome (MDS) [47,48] or as an 
isolated lissencephaly sequence (ILS) [49,50]. PAFAH1B1 gene 
is located in 17p 13.3 which is the most frequently deleted chro-
mosomal region in MDS and ILS patients [51]. So far, it is esti-
mated that 65% of ILS patients have deletions or intragenic mu-
tations of PAFAH1B1 [50]. PAFAH1B1 is a microtubule-associ-
ated phosphoprotein and its direct interaction with cytoplasmic 
dynein heavy change is important for neuronal migration, dis-
ruptions of which result in lissencephaly [52,53].
Mutations in KATNB1 (LIS6) are associated with complex ce-
rebral malformations known as lissencephaly 6 (microcephaly 
co-existing with lissencephaly) [54,55]. KATNB1 encodes the 
p80 subunit of katanin, a microtubule-associated ATPase 
[56,57] which consists of two subunits [56]. While p60 subunit 
provides the catalytic function, p80 subunit is the regulatory el-
ement that targets this protein to centrosomes and maintains the 
length of microtubules in developing neurons [58,59].
Mutations in LRRK2 are the most common cause of autoso-
mal dominant Parkinson’s disease [60,61]. To date, more than a 
hundred mutations of LRRK2 have been identified and six of 
them are confirmed to be pathogenic [62]. LRRK2 protein binds 
to the synaptic vesicles and regulates vesicular trafficking by in-
teracting with pre-synaptic proteins such as actin and synapsin 
[63]. The sequence variation of glycine to arginine at residue 
238 (G2385R) which is located between the 5th and 6th WDR 
domain has been confirmed as a risk factor in the Asian popula-
tion [64-66]. This mutation modifies LRRK2 protein structure, 
likely altering its binding affinity to synaptic vesicles and other 
interactors required for vesicle trafficking [67]. 
Cockayne syndrome type A (CSA) is a rare neurodegenera-
tive disorder characterized by complex phenotypes including a 
growth delay, optic atrophy, deafness, abnormalities in limb and 
digits, and mental disability [15,68]. According to the Human 
Gene Mutation Database (http://www.hgmd.cf.ac.uk/ac/gene.
php?gene=ERCC8), up to 70 mutations of the ERCC8 gene 
have been reported in CSA so far. ERCC8 is a subunit of E3 
ubiquitin ligase complex [13,14] and interacts with ERCC6 dur-
ing transcription-coupled nucleotide excision repair [13]. 
ERCC6, a putative helicase, is recruited by stalled RNA poly-
merase 2 on the DNA damage site and initiates DNA repair by 
attracting repair proteins including ERCC8 to the lesion [13,15]. 
Triple-A syndrome (AAAS) is a rare autosomal recessive dis-
order and patients suffer from adrenal insufficiency, achalasia of 
the oesophagal cardia, alacrimia, and neurological abnormali-
ties affecting the central, peripheral, and autonomic nervous 
systems [69,70]. Mutations of ALADIN have been found in all 
AAAS patients, which results in a truncated protein with loss of 
function [71]. ALADIN protein is normally localised within nu-
clear pore complexes [18] but mutants of ALADIN are shown 
to be sequestered in the cytoplasm [72], leading to impaired nu-
clear transport of proteins that are required to protect the nucle-
us from oxidative damage [73,74].
Mutations in WDR4 are reported in patients with microcepha-
ly with severe growth deficiency, seizures, and brain malforma-
tions [75,76]. Recent whole-exome sequencing analyses of a 
family with Galloway-Mowat syndrome (GAMOS) identified a 
novel mutation of WDR4 [77]. GAMOS present clinically het-
erogeneous phenotypes which combine renal failure and brain 
anomalies [78], with additionally associated features including 
facial dysmorphism, growth retardation and skeletal anomalies 
[79]. Fibroblast cells derived from patients with GAMOS show 
defective growth and altered microtubule networks [80]. WDR4 
is the human ortholog of yeast Trm82p and forms a complex 
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Table 1. List of WDR Proteins Associated with Neurological Disorders
WDR protein Associated diseases MIM number Mode of inheritance
LRRK2 Parkinson disease 607060 AD
PPP2R2B Spinocerebellar ataxia 604326 AD
TBL1XR1 Mental retardation
Pierpont syndrome
616944
602342
AD
AD
ERCC8 Cockayne syndrome, type A
UV-sensitive syndrome
216400
614621
AR
AR
PAFAH1B1 (LIS1) Lissencephaly
Subcortical laminar heterotopia
607432
607432
AD
AD
WDR26 Skraban-Deardorff syndrome 617616 AD
WIPI2 Intellectual developmental disorder with short stature and variable skeletal anomalies 618453 AR
COPB2 Primary microcephaly 617800 AR
DYNC1I2 Neurodevelopmental disorder with microcephaly and structural brain anomalies 618492 AR
ELP2 Mental disability 617270 AR
GNB4 Charcot-Marie-Tooth disease 615185 AD
SEC31A Neurodevelopmental disorder with spastic quadriplegia, optic atrophy, seizures, and  
structural brain anomalies
618651 AR
DCAF8 Giant axonal neuropathy 610100 AD
DMXL2 Deafness
Polyendocrine-polyneuropathy syndrome
Early infantile epileptic encephalopathy
617605
616113
618663
AD
AR
AR
EML1 Band heterotopia 600348 AR
PHIP Chung-Jansen syndrome 617991 AD
PLAA Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies 617527 AR
WDFY3 Primary microcephaly 617520 AD
WDR62 Primary microcephaly, with or without cortical malformations 604317 AR
AAAS Achalasia-addisonianism-alacrimia syndrome 231550 AR
BRWD3 X-linked mental disability 300659 XLR
GNB5 Intellectual developmental disorder with cardiac arrhythmia
Language delay and ADHD/cognitive impairment with or without cardiac arrhythmia
617173
617182
AR
AR
HERC1 Macrocephaly, dysmorphic faces, and psychomotor retardation 617011 AR
KATNB1 Lissencephaly, with microcephaly 616212 AR
RIC1 CATIFA syndrome 618761 AR
THOC6 Beaulieu-Boycott-Innes syndrome 613680 AR
WDR45 Neurodegeneration with brain iron accumulation 300894 XLD
WDR45B Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or  
without seizures
617977 AR
NUP37 Primary microcephaly 618179 AR
WDR37 Neuro-oculo-cardio-genitourinary syndrome 618652 AD
WDR4 Galloway-Mowat syndrome
Microcephaly, growth deficiency, seizures, and brain malformations
618347
618346
AR
AR
WDR73 Galloway-Mowat syndrome 251300 AR
WDR, WD40-repeat; MIM, Mendelian Inheritance in Man; AD, autosomal dominant; AR, autosomal recessive; UV, ultraviolet light; XLR, X-linked re-
cessive; ADHD, attention deficit hyperactivity disorder; CATIFA, cleft lip, cataract, tooth abnormality, impaired intellectual development, facial dysmor-
phism, attention-deficit hyperactivity; XLD, X-linked dominant.
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with N7-methylguanosine tRNA methyltransferase and MET-
TL1, which is essentially required for mRNA translation and 
stem cell self-renewal and differentiation [20,21]. WDR73 is 
another WDR protein related to GAMOS [81]. WDR73 is con-
centrated in the microtubule and interacts with several proteins 
critical to cell cycle and survival, such as tubulins α/β/γ and 
Hsp70/ 90 [81].
WDR proteins and cancer predisposition
WDR protein PALB2 is a breast and pancreatic cancer suscepti-
bility factor that interacts with BRCA2 and RAD51C [17,37] 
facilitating their DNA repair function [82]. Cancer-associated 
PALB2 mutations cause the loss of its binding ability to 
BRCA2/RAD51C and biallelic mutations of PALB2 are associ-
ated with an increased occurrence of childhood cancers [82]. 
Another WDR protein FBXW7 is a ubiquitin ligase substrate 
receptor and the most commonly deregulated ubiquitin/protea-
some system (UPS) protein in human cancer [16]. FBXW7 is a 
tumour suppressor protein that binds to the phosphorylated cy-
clin E and mediates its degradation by ubiquitination [16,17]. 
Loss-of-function mutations of FBXW7 result in inappropriate 
accumulation of cyclin E [17], which is observed in 18% of 
colorectal cancers, 15% of uterine endometrial carcinoma and 
40% of uterine carcinosarcoma [16,17].
WDR proteins associated with ciliopathies 
To date, mutations in at least 17 different WDR proteins have 
been identified in ciliopathies (see below and Table 2). Muta-
tions in all components of IFT-A complex—WDR10/IFT122 
[83], WDR19/IFT144 [84], WDR35/IFT121 [85], IFT43 [86], 
Table 2. List of WDR Proteins Associated with Ciliopathies
WDR protein Associated ciliopathy phenotypes MIM number Mode of inheritance
AHI1 Joubert syndrome 608629 AR
WDR19 Cranioectodermal dysplasia 
Short-rib thoracic dysplasia with or without polydactyly
Nephronophthisis
Senior-Loken syndrome
614378
614376
614377
616307
AR
AR
AR
AR
MAPKBP1 Nephronophthisis 617271 AR
WDR35 Cranioectodermal dysplasia
Short-rib thoracic dysplasia with or without polydactyly
613610
614091
AR
AR
WDR66 Spermatogenic failure 618152 AR
WDR81 Cerebellar ataxia, mental retardation, and dysequilibrium syndrome
Congenital hydrocephalus with brain anomalies
610185
617967
AR
AR
CFAP43 Hydrocephalus (normal pressure)
Spermatogenic failure 
236690
617592
AD
AR
CFAP44 Spermatogenic failure 617593 AR
DNAI1 Primary ciliary dyskinesia, with or without situs inversus 244400 AR
DNAI2 Primary ciliary dyskinesia, with or without situs inversus 612444
IFT122 Cranioectodermal dysplasia 218330 AR
IFT140 Retinitis pigmentosa
Short-rib thoracic dysplasia, with or without polydactyly
617781
266920
AR
AR
IFT172 Retinitis pigmentosa
Short-rib thoracic dysplasia, with or without polydactyly
616394
615630
AR
AR
IFT80 Short-rib thoracic dysplasia, with or without polydactyly 611263 AR
WDPCP Bardet-Biedl syndrome
Congenital heart defects, hamartomas of tongue, and polysyndactyly
615992
217085
AR
AR
WDR34 Short-rib thoracic dysplasia, with or without polydactyly 615633 AR
WDR60 Short-rib thoracic dysplasia, with or without polydactyly 615503 AR
WDR, WD40-repeat; MIM, Mendelian Inheritance in Man; AR, autosomal recessive; AD, autosomal dominant.
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IFT140 [87], TTC21B [88]—and a subset of proteins in IFT-B 
complex—WDR56/IFT80 [89], IFT172 [90], IFT52 [91], 
IFT81 [92]—have been identified in skeletal ciliopathies. Cra-
nio-ectodermal dysplasia (CED), also known as Sensenbrenner 
syndrome, is a ciliopathy characterized by craniofacial and skel-
etal anomalies [93]. So far, four IFT-A proteins are reported to 
be mutated in CED, namely, WDR10/IFT122, WDR19/IFT144, 
WDR35/IFT121, and IFT43 [87,94-97]. Mutations in WDR19/
IFT144 have also been identified in patients with Jeune syn-
drome, also known as asphyxiating thoracic dystrophy (ATD), 
presenting short stature, short digits (brachydactyly), and respi-
ratory distress due to insufficient rib bone growth [84]. WDR35/
IFT121 mutations are found in both Jeune syndrome and Short-
Rib-Polydactyly syndrome (SRPS) [98]. Mutations in WDR34 
and WDR60 are also associated with ATD and SRPS [98,99]. 
WDR34 and WDR60 are subunits of the dynein-2 complex, 
comprising the two intermediate chains of dynein-2 which me-
diates retrograde ciliary transport via IFT-A [100,101]. In addi-
tion to WDR34 and WDR60, disruptions in other dynein-2 sub-
units are also common causes of ATD and SRPS [89-91]. 
Therefore, patients with CED, ATD, and SRPS share clinical 
and genetic features [102] and can also be affected in non-skele-
tal organs including kidney, eye, liver, and heart [99].
AHI1 encodes a protein called Jouberin which contains seven 
WDR domains [103]. Recessive mutations of AHI1 underlie 
Joubert syndrome (JS) characterized by abnormal development 
of brain structures, including the cerebellar vermis and the 
brainstem, which resemble the cross-section of a molar tooth in 
MRI, thus nicknamed as ‘molar tooth malformation’ [103,104]. 
JS patients show additional distinctive features including ocular 
coloboma, polycystic kidney and polydactyly, which are collec-
tively referred to as JS-related disorders (JSRD) [105,106]. 
AHI1 mutation is also associated with a broad range of neuro-
logical disorders including schizophrenia [107] and autism 
[108]. Recent mouse model studies have revealed that Ahi1 is 
highly expressed in the postnatal brain and interacts with other 
proteins crucial for neuronal differentiation [109,110].
WDR proteins in endocrine disorders
Table 3 lists the WDR proteins involved in endocrine disorders, 
many of which are often presented as a part of a ciliopathy. Sev-
eral signalling receptors important in neuro-endocrine functions 
are shown to localise to primary cilia [111]. They include kiss-
peptin receptor (KISS1R) [112], type 1 dopaminergic receptor 
(D1R), beta-2 adrenergic receptor (B2AR) [113], serotonin re-
ceptor 6 (5-HT6) [114], and insulin-like growth factor 1 recep-
tor (IGF1R) [115]. It has been suggested that the spatio-tempo-
ral distribution and concentration of these receptors on the cili-
ary membrane surface may provide an additional level of regu-
lation for the signal capacity and specificity of these receptors 
[116]. Shortening of cilia length and alteration in ciliation fre-
quency can indicate functional disruption of cilia-dependent re-
ceptor signalling and protein trafficking, involved in endocrine 
functions. 
WDR11 is a scaffolding protein required for normal ciliogen-
esis. Mutations of WDR11 have been identified in congenital 
isolated hypogonadotropic hypogonadism (CHH), septo-optic 
dysplasia (SOD), combined pituitary hormone deficiency 
(CPHD), and pituitary stalk interruption syndrome [117-120]. 
CHH is defined by the absent or delayed puberty due to defec-
tive gonadotrophin-releasing hormone secretion or action. CHH 
can present with a normal sense of smell (normosmic CHH) or 
defective sense of smell (hyposmic/anosmic CHH or Kallmann 
syndrome) [121,122]. CHH patients often show other associated 
Table 3. List of WDR Proteins Associated with Endocrine Disorders
WDR protein Disease name Endocrine-related phenotypes MIM number Mode of inheritance
TBL1X Congenital non-goitrous hypothyroidism Hypothyroidism 301033 XL
WDR11 Kallmann syndrome Hypogonadotropic hypogonadism with or without  
anosmia
614858 AD
AHI1 Joubert syndrome Isolated growth hormone deficiency micropenis 608629 AR
WDPCP Bardet-Biedl syndrome Obesity
Hypogonadism in males
615992 AR
DMXL2 Polyendocrine-polyneuropathy syndrome Hypothyroidism 616113 AR
AAAS Achalasia-addisonianism-alacrimia  
syndrome
Multisystem disorder wiwth endocrine, gastrointestinal, 
ocular, and neurologic manifestations.
231550 AR
WDR, WD40-repeat; MIM, Mendelian Inheritance in Man; XL, X-linked; AD, autosomal dominant; AR, autosomal recessive.
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features such as midline defects (cleft lip or palate), deformity 
of hands and feet, neurosensory hearing loss, and ocular motor 
abnormalities [123-125]. Previous studies have suggested that 
CHH, SOD, and CPHD are genetically overlapping conditions 
[120]. Clinically identified mutations of WDR11 caused defec-
tive cilia formation, and targeted disruption of WDR11 in ani-
mal models resulted in dysgenesis of multiple organs affected in 
CHH and Kallmann syndrome [126]. Hedgehog signalling 
pathway which depends on the normal function of primary cilia 
is also shown to be disrupted by the loss of WDR11. Based on 
these findings, it was suggested that CHH and Kallmann syn-
drome could be considered as a ciliopathy [126]. The endocrine 
feature is also common in other ciliopathies such as JS and 
JSRD. Some JS/JSRD patients show growth hormone or thy-
roid hormone deficiency [127], CPHD [128], and micropenis 
[129].
WDR proteins have been associated with obesity. GNB3 is 
related to childhood obesity and polymorphism of GNB3 is as-
sociated with obesity, hypertension, and diabetes type 2 [130-
132]. A genome-wide association study identified WDR11 as a 
novel genetic locus associated with childhood obesity [133]. 
Siblings sharing a rare variant of WDR11 gene showed obesity 
with attention deficit hyperactivity disorder [126]. Obesity is, in 
fact, one of the main features of Bardet-Biedl syndrome (BBS) 
[134]. BBS is a ciliopathy with a wide spectrum of clinical fea-
tures including rod-cone dystrophy, polydactyly, hypogonadism 
in male and renal abnormalities [135]. Homozygous mutation in 
WDPCP (also called BBS15) is identified in BBS patients with 
obesity and male hypogonadism [136]. WDPCP is involved in 
planar polarity effectors (CPLANE) complex required for re-
cruitment of IFT-A proteins during ciliogenesis [137]. 
Mutations of TBL1X have been identified in isolated congen-
ital central hypothyroidism [138]. Congenital hypothyroidism 
(CH) is a thyroid hormone deficiency at birth caused by the im-
paired function of the thyroid itself (primary CH) or defective 
stimulation of thyroid gland by a thyroid-stimulating hormone 
(central or secondary CH) [139]. Central CH can be categorized 
into two subtypes—isolated thyroid hormone deficiency and 
CPHD [139]. Isolated thyroid hormone deficiency accounts for 
40% of central CH cases [140] and can be caused by mutations 
in four genes that regulate the thyroid-stimulating hormone bio-
synthesis, including β subunit of thyroid-stimulating hormone 
(TSHβ), receptor for thyrotropin-releasing hormone (TRHR), 
IGSF1 (the regulator for TRHR expression in the pituitary) and 
TBL1X (an essential subunit of the thyroid hormone receptor 
corepressor complex) [24,138].
Although AAAS was described as a neurological disorder 
previously, the adrenal glands are one of the primarily affected 
organs [71,141]. About 85% of AAAS patients show adrenocor-
ticotropin hormone resistant adrenal insufficiency due to im-
paired glucocorticoid secretion [142] and a subsequence adrenal 
androgen deficiency is also observed [143]. Homozygous dele-
tion of DMXL2 is identified in patients with the polyendocrine-
polyneuropathy syndrome (PEPNS) [144]. PEPNS refers to a 
combined symptom including CHH with hypothyroidism, hy-
poglycemia, peripheral polyneuropathy, and mental disability 
[143]. A recent study has shown that gonad specific DMXL2 
deletion causes impaired spermatogenesis in males [145].
CONCLUSIONS
WDR proteins are widely expressed in human tissues and high-
ly conserved in vertebrates (https://www.proteinatlas.org/
search/wdr). Thanks to the recent advancements in genome se-
quencing analysis, many potentially pathogenic variants of 
WDR proteins have been identified, which can prove to be 
powerful tools for assigning new functions to the WDR motifs 
and associated domains. It is possible that WDR proteins with 
very similar surfaces have common binding partners or similar 
functions. Mutations in WDR proteins underlie a broad spec-
trum of human pathologies including neurological disorders, 
cancer, ciliopathies, and endocrine disorders. These are complex 
disorders, thus a clear understanding of the clinical phenotypes 
and comprehensive diagnosis are often challenging. Molecular 
mechanisms through which WDR proteins are involved in these 
diverse conditions remain largely unknown. A better under-
standing of WDR proteins and their interacting partners may of-
fer some clues. The new insights for WDR-related diseases and 
their underlying mechanisms as provided in this review may 
help develop therapeutic approaches targeting the common 
WDR motifs involved.
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Supplemental Table S1. Full List of WDR Proteins Accessed
Gene name Full name of the protein Alternative name of the gene Gene ID from NCBI RefSeq
A6NM71 PRA1 family protein 10567
A6P4T4 Tyrosine-protein kinase receptor
A6P4V4 Tyrosine-protein kinase receptor
A8MWR8 Highly similar to SEC13-related protein 6396
AAAS Aladin WD repeat nucleoporin AAA, AAASb, ADRACALA, ADRA-
CALIN, ALADIN, GL003
8086
AAMP Angio associated migratory cell protein 14
AHI1 Abelson helper integration site 1 AHI-1, JBTS3, ORF1, dJ71N10.1 54806
AMBRA1 Autophagy and beclin 1 regulator 1 DCAF3, WDR94 55626
APAF1 Apoptotic peptidase activating factor 1 APAF-1, CED4 317
ARPC1A Actin related protein 2/3 complex subunit 1A Arc40, HEL-68, HEL-S-307, SOP2Hs, 
SOP2L
10552
ARPC1B Actin related protein 2/3 complex subunit 1B ARC41, PLTEID, p40-ARC, p41-ARC 10095
ATG16L1 Autophagy related 16 like 1 APG16L, ATG16A, ATG16L, IBD10, 
WDR30
55054
ATG16L2 Autophagy related 16 like 2 ATG16B, WDR80 89849
B3KMW5 Highly similar to WD repeat protein 3
B3KP68 Highly similar to homo sapiens selective LIM binding factor
B3KP80 Highly similar to BTB/POZ domain-containing protein KCTD3
B3KRR8 Highly similar to WD repeat protein 6 11180
B3KUA2 Highly similar to transducin-like enhancer protein 3 7090
B3KVI6 Highly similar to lipopolysaccharide-responsive and beige-like anchor 
protein
B3KXA3 Highly similar to homo sapiens echinoderm microtubule associated 
protein like 1 (EML1)
B3KXN4 Highly similar to WD repeat protein 1
B4DDD4 WD repeat-containing protein 27 WDR27 253769
B4DDU7 Highly similar to aladin
B4DE62 Highly similar to transducin-like enhancer protein 2
B4DEF9 Highly similar to transducin-like enhancer protein 1 7088
B4DGB7 Highly similar to homo sapiens WD repeat domain 10 (WDR10)
B4DGE3 Highly similar to homo sapiens SEC31-like 2 (SEC31L2), transcript 
variant 1
B4DK45 Highly similar to WD repeat protein 6
B4DL97 Highly similar to homo sapiens echinoderm microtubule associated 
protein like 3
256364
B4DMH3 Coronin
B4DN30 Highly similar to WD repeat protein 21A 26094
B4DNL1 Highly similar to periodic tryptophan protein 1 homolog
B4DPZ3 Highly similar to cytoplasmic dynein 1 intermediate chain 2 1781
B4DT22 Highly similar to peptidylprolyl isomerase domain and WD repeat-
containing protein 1
23398
B4DTI1 Moderately similar to glutamate-rich WD repeat-containing protein 1
B4DVD2 Highly similar to guanine nucleotide-binding protein subunit beta 
2-like 1
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Gene name Full name of the protein Alternative name of the gene Gene ID from NCBI RefSeq
B4DVM5 Highly similar to WD repeat protein 24
B4DVQ7 Highly similar to WD repeat protein 13
B4DVX0 Highly similar to neurobeachin-like 1
B4DWC6 Highly similar to guanine nucleotide-binding protein subunitbeta 2-like 1
B4DX09 Moderately similar to bromodomain and WD repeat domain-containing 
protein 2
B4DX93 Highly similar to cytoplasmic dynein 1 intermediate chain 2
B4DYK8 B4DYK8
B4DZX5 Moderately similar to homo sapiens WD repeat domain 1 (WDR1), 
transcript variant 2
B4E018 Highly similar to WD repeat protein 74
B4E068 Moderately similar to WD repeat protein 79
B4E074 Highly similar to Notchless homolog 1
B4E0E6 Highly similar to homo sapiens denticleless homolog (DTL) 51514
B4E1H5 Highly similar to cell division cycle protein 20 homolog
B4E286 Highly similar to WD repeat protein 19
B4E2R3 Highly similar to homo sapiens G protein beta subunit-like (GBL)
B4E303 Highly similar to Notchless homolog 1
B4E345 Weakly similar to protein groucho
B4E383 Highly similar to DNA excision repair protein ERCC-8
B4E3M9 Highly similar to breast carcinoma amplified sequence 3
B6EXY3 Tyrosine-protein kinase receptor
B7Z2F5 Highly similar to echinoderm microtubule-associated protein-like 2
B7Z2P6 Highly similar to homo sapiens WD repeat domain 42A (WDR42A)
B7Z475 Highly similar to F-box-like/WD repeat protein TBL1XR1
B7Z6H0 Highly similar to sterol regulatory element-binding protein cleavage-
activating protein
22937
B7Z872 Highly similar to echinoderm microtubule-associated protein-like 2
B7Z918 Highly similar to echinoderm microtubule-associated protein-like 2
BCAS3 BCAS3 microtubule associated cell migration factor MAAB, GAOB1 54828
BOP1 BOP1 ribosomal biogenesis factor 23246
BRWD1 Bromodomain and WD repeat domain containing 1 C21orf107, DCAF19, N143, WDR9, WRD9 54014
BRWD3 Bromodomain and WD repeat domain containing 3 BRODL, MRX93 254065
BTRC Beta-transducin repeat containing E3 ubiquitin protein ligase BETA-TRCP, FBW1A, FBXW1, FBXW1A, 
FWD1, bTrCP, bTrCP1, betaTrCP
8945
BUB3 BUB3 mitotic checkpoint protein BUB3L, hBUB3 9184
C2ORF44 WD repeat and coiled coil containing WDCP, MMAP, PP384 80304
CDC20 Cell division cycle 20 CDC20A, bA276H19.3, p55CDC 991
CDC20B Cell division cycle 20B G6VTS76519 166979
CDC40 Cell division cycle 40 EHB3, PRP17, PRPF17 51362
CDRT1 CMT1A duplicated region transcript 1 C170RF1, C17ORF1, C17ORF1A,  
FBXW10B, FBXW10P1, HREP, SM25H2
374286
CFAP43 Cilia and flagella associated protein 43 C10orf79, HYDNP1, SPGF19, WDR96, 
bA373N18.2
80217
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CFAP44 Cilia and flagella associated protein 44 SPGF20, WDR52 55779
CFAP52 Cilia and flagella associated protein 52 WDR16, WDRPUH 146845
CFAP57 Cilia and flagella associated protein 57 VWS2, WDR65 149465
CHAF1B Chromatin assembly factor 1 subunit B CAF-1, CAF-IP60, CAF1, CAF1A, 
CAF1P60, MPHOSPH7, MPP7
8208
CIAO1 Cytosolic iron-sulfur assembly component 1 CIA1, WDR39 9391
CIRH1A UTP4 small subunit processome component UTP4, CIRHIN, NAIC, TEX292 84916
COPA COPI coat complex subunit alpha AILJK, HEP-COP, alpha-COP 1314
COPB2 COPI coat complex subunit beta 2 MCPH19, beta’-COP 9276
CORO1A Coronin 1A CLABP, CLIPINA, HCORO1, IMD8, 
TACO, p57
11151
CORO1B Coronin 1B CORONIN-2 57175
CORO1C Coronin 1C HCRNN4 23603
CORO2A Coronin 2A CLIPINB, IR10, WDR2 7464
CORO2B Coronin 2B CLIPINC 10391
CORO6 Coronin 6 84940
CORO7 Coronin 7 0610011B16Rik, CRN7, POD1 79585
CSTF1 Cleavage stimulation factor subunit 1 CstF-50, CstFp50 1477
DAW1 Dynein assembly factor with WD repeats 1 ODA16, WDR69 164781
DCAF10 DDB1 and CUL4 associated factor 10 WDR32 79269
DCAF11 DDB1 and CUL4 associated factor 11 GL014, PRO2389, WDR23 80344
DCAF12 DDB1 and CUL4 associated factor 12 CT102, TCC52, WDR40A, KIAA1892 25853
DCAF12L1 DDB1 and CUL4 associated factor 12 like 1 KIAA1892L, WDR40B 139170
DCAF12L2 DDB1 and CUL4 associated factor 12 like 2 WDR40C 340578
DCAF13 DDB1 and CUL4 associated factor 13 GM83, HSPC064, Sof1, WDSOF1 25879
DCAF4 DDB1 and CUL4 associated factor 4 WDR21, WDR21A 26094
DCAF4L1 DDB1 and CUL4 associated factor 4 like 1 WDR21B 285429
DCAF4L2 DDB1 and CUL4 associated factor 4 like 2 WDR21C 138009
DCAF5 DDB1 and CUL4 associated factor 5 BCRG2, BCRP2, D14S1461E, WDR22 8816
DCAF6 DDB1 and CUL4 associated factor 6 1200006M05Rik, ARCAP, IQWD1, 
MSTP055, NRIP, PC326
55827
DCAF7 DDB1 and CUL4 associated factor 7 AN11, HAN11, SWAN-1, WDR68 10238
DCAF8 DDB1 and CUL4 associated factor 8 GAN2, H326, WDR42A 50717
DCAF8L1 DDB1 and CUL4 associated factor 8 like 1 WDR42B 139425
DCAF8L2 DDB1 and CUL4 associated factor 8 like 2 WDR42C 347442
DDB2 Damage specific DNA binding protein 2 DDBB, UV-DDB2, XPE 1643
DENND3 DENN domain containing 3 22898
DKFZ-
P434D199
U5 small nuclear ribonucleoprotein 40 kDa protein SNRNP40
DKFZ-
P451A177
Uncharacterized protein DKFZp451A177 DKFZp451A177
DKFZ-
P779C159
Uncharacterized protein DKFZp779C159 DKFZp779C159
DMWD DM1 locus, WD repeat containing D19S593E, DMR-N9, DMRN9, gene59 1762
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DMXL1 Dmx like 1 1657
DMXL2 Dmx like 2 RC3, PEPNS, DFNA71, EIEE81 23312
DNAI1 Dynein axonemal intermediate chain 1 CILD1, DIC1, ICS1, PCD 27019
DNAI2 Dynein axonemal intermediate chain 2 CILD9, DIC2 64446
DPH7 Diphthamide biosynthesis 7 C9orf112, RRT2, WDR85 92715
DTL Denticleless E3 ubiquitin protein ligase homolog CDT2, RAMP, DCAF2, L2DTL 51514
DYNC1I1 Dynein cytoplasmic 1 intermediate chain 1 DNCI1, DNCIC1 1780
DYNC1I2 Dynein cytoplasmic 1 intermediate chain 2 DIC74, DNCI2, IC2, NEDMIBA 1781
EDC4 Enhancer of mRNA decapping 4 GE1, Ge-1, RCD8, HEDL5, HEDLS,  
RCD-8
23644
EED Embryonic ectoderm development EED, COGIS, WAIT1 8726
EIF2A Eukaryotic translation initiation factor 2A CDA02, EIF-2A, MST089, MSTP004, 
MSTP089
83939
EIF3B Eukaryotic translation initiation factor 3 subunit B EIF3-ETA, EIF3-P110, EIF3-P116, EIF3S9, 
PRT1
8662
EIF3I Eukaryotic translation initiation factor 3 subunit I EIF3S2, PRO2242, TRIP-1, TRIP1, eIF3-
beta, eIF3-p36
8668
ELP2 Elongator acetyltransferase complex subunit 2 StIP, MRT58, SHINC-2, STATIP1 55250
EML1 EMAP like 1 BH, ELP79, EMAP, EMAP-1, EMAPL 2009
EML2 EMAP like 2 ELP70, EMAP-2, EMAP2 24139
EML3 EMAP like 3 ELP95, EMAP3, EMAP95 256364
EML4 EMAP like 4 C2orf2, ELP120, EMAP-4, EMAPL4, 
ROPP120
27436
EML4-ALK Tyrosine-protein kinase receptor EML4-ALK
EML5 EMAP like 5 EMAP-2, EMAP-5, FAP16 161436
EML6 EMAP like 6 400954
ERCC8 ERCC excision repair 8, CSA ubiquitin ligase complex subunit CSA, CKN1, UVSS2 1161
FBXW10 F-box and WD repeat domain containing 10 Fbw10, HREP, SM25H2, SM2SH2 10517
FBXW11 F-box and WD repeat domain containing 11 BTRC2, BTRCP2, FBW1B, FBXW1B, 
Fbw11, Hos
23291
FBXW12 F-box and WD repeat domain containing 12 FBW12, FBXO12, FBXO35 285231
FBXW2 F-box and WD repeat domain containing 2 Md6, FBW2, Fwd2 26190
FBXW4 F-box and WD repeat domain containing 4 DAC, FBW4, FBWD4, SHFM3, SHSF3 6468
FBXW5 F-box and WD repeat domain containing 5 Fbw5 54461
FBXW7 F-box and WD repeat domain containing 7 AGO, CDC4, FBW6, FBW7, FBX30, 
FBXO30, FBXW6, SEL-10, SEL10, 
hAgo, hCdc4
55294
FBXW8 F-box and WD repeat domain containing 8 FBW6, FBW8, FBX29, FBXO29, FBXW6 26259
FBXW9 F-box and WD repeat domain containing 9 Fbw9, MEC-15 84261
FLJ00012 FLJ00012 protein 89849
FLJ00025 FLJ00025 protein FLJ00025
FZR1 Fizzy and cell division cycle 20 related 1 CDC20C, CDH1, FZR, FZR2, HCDH, 
HCDH1
51343
GEMIN5 Gem nuclear organelle associated protein 5 GEMIN-5 25929
GNB1 G protein subunit beta 1 MRD42 2782
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GNB1L G protein subunit beta 1 like DGCRK3, FKSG1, GY2, WDR14,  
WDVCF
54584
GNB2 G protein subunit beta 2 2783
GNB2L1 Receptor for activated C kinase 1 GNB2L1, Gnb2-rs1, H12.3, HLC-7, 
PIG21
10399
GNB3 G protein subunit beta 3 CSNB1H 2784
GNB4 G protein subunit beta 4 CMTD1F 59345
GNB5 G protein subunit beta 5 GB5, IDDCA, LADCI, gbeta5 10681
GRWD1 Glutamate rich WD repeat containing 1 CDW4, GRWD, RRB1, WDR28 83743
GTF3C2 General transcription factor IIIC subunit 2 TFIIIC-BETA, TFIIIC110 2976
H0YL77 Uncharacterized protein
H3BRJ5 Uncharacterized protein
HERC1 HECT and RLD domain containing E3 ubiquitin protein ligase family 
member 1
p532, p619, MDFPMR 8925
HIRA Histone cell cycle regulator DGCR1, TUP1, TUPLE1 7290
HPS5 HPS5 biogenesis of lysosomal organelles complex 2 subunit 2 AIBP63, BLOC2S2 11234
IFT122 Intraflagellar transport 122 CED, CED1, FAP80, SPG, WDR10, 
WDR10p, WDR140
55764
IFT140 Intraflagellar transport 140 MZSDS, RP80, SRTD9, WDTC2, 
c305C8.4, c380F5.1, gs114
9742
IFT172 Intraflagellar transport 172 BBS20, NPHP17, RP71, SLB, SRTD10, 
osm-1, wim
26160
IFT80 Intraflagellar transport 80 ATD2, FAP167, SRTD2, WDR56 57560
KATNB1 Katanin regulatory subunit B1 KAT, LIS6 10300
KCTD3 Potassium channel tetramerization domain containing 3 NY-REN-45 51133
KIF21A Kinesin family member 21A CFEOM1, FEOM1, FEOM3A 55605
KIF21B Kinesin family member 21B 23046
LLGL1 LLGL scribble cell polarity complex component 1 DLG4, HUGL, LLGL, Lgl1, Mgl1, 
HUGL1, HUGL-1
3996
LLGL2 LLGL scribble cell polarity complex component 2 HGL, Hugl-2, LGL2 3993
LRBA LPS responsive beige-like anchor protein BGL, CDC4L, CVID8, LAB300, LBA 987
LRRK2 Leucine rich repeat kinase 2 PARK8, RIPK7, ROCO2, AURA17, 
DARDARIN
120892
LRWD1 Leucine rich repeats and WD repeat domain containing 1 CENP-33, ORCA 222229
LYST Lysosomal trafficking regulator CHS, CHS1 1130
MAPKBP1 Mitogen-activated protein kinase binding protein 1 JNKBP-1, JNKBP1, NPHP20 23005
MED16 Mediator complex subunit 16 DRIP92, THRAP5, TRAP95 10025
MIOS Meiosis regulator for oocyte development MIO, Sea4, Yulink 54468
MLST8 MTOR associated protein, LST8 homolog GBL, GbetaL, LST8, POP3, WAT1 64223
NBAS NBAS subunit of NRZ tethering complex ILFS2, NAG, SOPH 51594
NBEA Neurobeachin BCL8B, LYST2 26960
NBEAL1 Neurobeachin like 1 A530083I02Rik, ALS2CR16, ALS2CR17 65065
NBEAL2 Neurobeachin like 2 BDPLT4, GPS 23218
NEDD1 NEDD1 gamma-tubulin ring complex targeting factor GCP-WD, TUBGCP7 121441
NLE1 Notchless homolog 1 NLE 54475
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NOL10 Nucleolar protein 10 79954
NSMAF Neutral sphingomyelinase activation associated factor FAN, GRAMD5 8439
NUP214 Nucleoporin 214 CAN, CAIN, IIAE9 8021
NUP37 Nucleoporin 37 MCPH24, p37 79023
NUP43 Nucleoporin 43 bA350J20.1, p42 348995
NWD1 NACHT and WD repeat domain containing 1 284434
NWD2 NACHT and WD repeat domain containing 2 KIAA1239 57495
PAAF1 Proteasomal ATPase associated factor 1 PAAF, Rpn14, WDR71 80227
PAFAH1B1 Platelet activating factor acetylhydrolase 1b regulatory subunit 1 LIS1, LIS2, MDCR, MDS, NudF, PAFAH 5048
PAK1IP1 PAK1 interacting protein 1 MAK11, PIP1, WDR84, bA421M1.5, 
hPIP1
55003
PALB2 Partner and localizer of BRCA2 FANCN, PNCA3 79728
PAN2 Poly(A) specific ribonuclease subunit PAN2 USP52 9924
PEX7 Peroxisomal biogenesis factor 7 PBD9B, PTS2R, RCDP1, RD 5191
PHIP Pleckstrin homology domain interacting protein ndrp, BRWD2, DIDOD, WDR11, 
DCAF14, CHUJANS
55023
PIK3R4 Phosphoinositide-3-kinase regulatory subunit 4 VPS15, p150 30849
PLAA Phospholipase A2 activating protein DOA1, NDMSBA, PLA2P, PLAP 9373
PLRG1 Pleiotropic regulator 1 Cwc1, PRL1, PRP46, PRPF46, TANGO4 5356
POC1A POC1 centriolar protein A PIX2, SOFT, WDR51A 25886
POC1B POC1 centriolar protein B PIX1, CORD20, TUWD12, WDR51B 282809
PPP2R2A Protein phosphatase 2 regulatory subunit B alpha B55A, PR52A, PR55A, B55ALPHA, 
PR55alpha
5520
PPP2R2B Protein phosphatase 2 regulatory subunit B beta B55BETA, PP2AB55BETA, PP2AB-
BETA, PP2APR55B, PP2APR55BETA, 
PR2AB55BETA, PR2ABBETA, PR2A-
PR55BETA, PR52B, PR55-BETA, PR-
55BETA, SCA12
5521
PPP2R2C Protein phosphatase 2 regulatory subunit B gamma B55-GAMMA, B55gamma, IMYPNO, 
IMYPNO1, PR52, PR55G
5522
PPP2R2D Protein phosphatase 2 regulatory subunit B delta B55D, B55delta, MDS026 55844
PPWD1 Peptidylprolyl isomerase domain and WD repeat containing 1 23398
PREB Prolactin regulatory element binding SEC12 10113
PRPF19 Pre-mRNA processing factor 19 PSO4, SNEV, PRP19, UBOX4, hPSO4, 
NMP200
27339
PRPF4 Pre-mRNA processing factor 4 HPRP4, HPRP4P, PRP4, Prp4p, RP70, 
SNRNP60
9128
PWP1 PWP1 homolog, endonuclein IEF-SSP-9502 11137
PWP2 PWP2 small subunit processome component EHOC-17, PWP2H, UTP1 5822
Q2VIM1 RcCDC20 RcCDC20
Q53F40 F-box protein FBW7 isoform 2 variant
Q59EB2 Uncharacterized protein 374286
Q59EY9 Transducin-like enhancer of split 3 splice variant 1 variant
Q59EZ2 Telomerase protein component 1 variant
Q59F81 Coronin
(Continued to the next page)
Supplemental Table S1. Continued
www.e-enm.org Endocrinol Metab 2020 Forthcoming. Posted online 2020
Kim Y, et al.
ARTICLE IN PRESS
Gene name Full name of the protein Alternative name of the gene Gene ID from NCBI RefSeq
Q59FM2 PWP2 periodic tryptophan protein homolog
Q59GC6 Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B
Q59GN6 WD repeat domain 23 isoform 1 variant 80344
Q6ZP32 Highly similar to Serine/threonine protein phosphatase 2A, 55 kDa 
regulatory subunit B
Q6ZS54 FLJ45821 fis
Q6ZW40 FLJ41631 fis
Q6ZW98 Moderately similar to Human actin binding protein p57
Q8N797 FLJ25882 fis
Q8N7X6 FLJ40237 fis
Q8TCI4 FLJ23854 fis
Q9H8N9 Weakly similar to BETA-TRCP (BETA-TRANSDUCIN REPEAT-
CONTAINING PROTEIN)
57590
Q9NWG8 FLJ10035 fis
Q9Y6S1 R26610_1
RAE1 Ribonucleic acid export 1 Gle2, MIG14, MRNP41, Mnrp41, 
dJ481F12.3, dJ800J21.1
8480
RBBP4 RB binding protein 4, chromatin remodeling factor NURF55, RBAP48 5928
RBBP5 RB binding protein 5, histone lysine methyltransferase complex subunit RBQ3, SWD1 5929
RBBP7 RB binding protein 7, chromatin remodeling factor RbAp46 5931
RFWD2 COP1–COP1 E3 ubiquitin ligase COP1, CFAP78, FAP78, RNF200 64326
RFWD3 Ring finger and WD repeat domain 3 FANCW, RNF201 55159
RIC1 RIC1 homolog, RAB6A GEF complex partner 1 CATIFA, CIP150, KIAA1432, 
bA207C16.1
57589
RPTOR Regulatory associated protein of MTOR complex 1 KOG1, Mip1 57521
RRP9 Ribosomal RNA processing 9, U3 small nucleolar RNA binding protein RNU3IP2, U3-55K 9136
SCAP SREBF chaperone 22937
SEC13 SEC13 homolog, nuclear pore and COPII coat complex component D3S1231E, SEC13L1, SEC13R, npp-20 6396
SEC31A SEC31 homolog A, COPII coat complex component ABP125, ABP130, HSPC275, HSPC334, 
NEDSOSB, SEC31L1
22872
SEC31B SEC31 homolog B, COPII coat complex component SEC31B-1, SEC31L2 25956
SEH1L SEH1 like nucleoporin Seh1, SEH1A, SEH1B, SEC13L 81929
SHKBP1 SH3KBP1 binding protein 1 PP203, Sb1 92799
SMU1 SMU1 DNA replication regulator and spliceosomal factor BWD, SMU-1, fSAP57 55234
SNRNP40 Small nuclear ribonucleoprotein U5 subunit 40 40K, HPRP8BP, PRP8BP, PRPF8BP, 
SPF38, WDR57
9410
SPAG16 Sperm associated antigen 16 PF20, WDR29 79582
STRAP Serine/threonine kinase receptor associated protein MAWD, PT-WD, UNRIP 11171
STRN STRN 6801
STRN3 Striatin 3 PPP2R6B, S/G2NA, SG2NA 29966
STRN4 Striatin 4 PPP2R6C, ZIN, zinedin 29888
STXBP5 Syntaxin binding protein 5 LGL3, LLGL3, Nbla04300 134957
STXBP5L Syntaxin binding protein 5 like LLGL4 9515
TAF5 TATA-box binding protein associated factor 5 TAF(II)100, TAF2D, TAFII-100, TAFII100 6877
(Continued to the next page)
Supplemental Table S1. Continued
Endocrinol Metab 2020 Forthcoming. Posted online 2020 www.e-enm.org
WDR Mutations in Human Diseases
ARTICLE IN PRESS
Gene name Full name of the protein Alternative name of the gene Gene ID from NCBI RefSeq
TAF5L TATA-box binding protein associated factor 5 like PAF65B 27097
TBC1D31 TBC1 domain family member 31 Gm85, WDR67 93594
TBL1X Transducin beta like 1 X-linked CHNG8, EBI, SMAP55, TBL1 6907
TBL1XR1 TBL1X receptor 1 C21, DC42, IRA1, MRD41, TBLR1 79718
TBL1Y Transducin beta like 1 Y-linked DFNY2, TBL1 90665
TBL2 Transducin beta like 2 WBSCR13, WS-betaTRP 26608
TBL3 Transducin beta like 3 SAZD, UTP13 10607
TECPR2 Tectonin beta-propeller repeat containing 2 KIAA0329, SPG49 9895
TEP1 Telomerase associated protein 1 TLP1, TP1, TROVE1, VAULT2, p240 7011
THOC3 THO complex 3 THO3, hTREX45 84321
THOC6 THO complex 6 WDR58, fSAP35 79228
TLE1 TLE family member 1, transcriptional corepressor ESG, ESG1, GRG1 7088
TLE2 TLE family member 2, transcriptional corepressor ESG, ESG2, GRG2 7089
TLE3 TLE family member 3, transcriptional corepressor ESG, ESG3, GRG3, HsT18976 7090
TLE4 TLE family member 4, transcriptional corepressor BCE-1, BCE1, E(spI), E(spl), ESG, ESG4, 
GRG4, Grg-4
7091
TLE6 TLE family member 6, subcortical maternal complex member GRG6, PREMBL 79816
TRAF7 TNF receptor associated factor 7 CAFDADD, RFWD1, RNF119 84231
TSSC1 EARP complex and GARP complex interacting protein 1 EIPR1, EIPR-1 7260
TULP4 TUB like protein 4 TUSP 56995
UTP15 UTP15 small subunit processome component NET21 84135
UTP18 UTP18 small subunit processome component CGI-48, WDR50 51096
UTP4 UTP4 small subunit processome component CIRH1A, CIRHIN, NAIC, TEX292 84916
VPRBP DCAF1–DDB1 and CUL4 associated factor 1 DCAF1, RIP 9730
WDF3 WD40-and FYVE-domain containing protein 3 WDF3
WDFY1 WD repeat and FYVE domain containing 1 FENS-1, FENS1, WDF1, ZFYVE17 57590
WDFY2 WD repeat and FYVE domain containing 2 PROF, WDF2, ZFYVE22 115825
WDFY3 WD repeat and FYVE domain containing 3 ALFY, BCHS, MCPH18, ZFYVE25 23001
WDFY4 WDFY family member 4 C10orf64 57705
WDHD1 WD repeat and HMG-box DNA binding protein 1 AND-1, AND1, CHTF4, CTF4 11169
WDPCP WD repeat containing planar cell polarity effector BBS15, C2orf86, CHDTHP, CPLANE5, 
FRITZ, FRTZ
51057
WDR1 WD repeat domain 1 AIP1, HEL-S-52, NORI-1 9948
WDR11 WD repeat domain 11 BRWD2, DR11, HH14, SRI1, WDR15 55717
WDR12 WD repeat domain 12 YTM1 55759
WDR13 WD repeat domain 13 MG21 64743
WDR17 WD repeat domain 17 116966
WDR18 WD repeat domain 18 Ipi3, R32184_1 57418
WDR19 WD repeat domain 19 ATD5, CED4, DYF-2, FAP66, ORF26, Oseg6, 
PWDMP, SRTD5, IFT144, NPHP13
57728
WDR20 WD repeat domain 20 DMR 91833
WDR24 WD repeat domain 24 C16orf21, JFP7 84219
WDR25 WD repeat domain 25 C14orf67 79446
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WDR26 WD repeat domain 26 CDW2, GID7, MIP2, SKDEAS 80232
WDR27 WD repeat domain 27 253769
WDR3 WD repeat domain 3 DIP2, UTP12 10885
WDR31 WD repeat domain 31 114987
WDR33 WD repeat domain 33 NET14, WDC146 55339
WDR34 Dynein 2 intermediate chain 2 CFAP133, DIC5, FAP133, SRTD11, WDR34, 
bA216B9.3
89891
WDR35 WD repeat domain 35 CED2, FAP118, IFT121, IFTA1, SRTD7 57539
WDR36 WD repeat domain 36 GLC1G, TA-WDRP, TAWDRP, UTP21 134430
WDR37 WD repeat domain 37 NOCGUS 22884
WDR38 WD repeat domain 38 401551
WDR4 WD repeat domain 4 GAMOS6, MIGSB, TRM82, TRMT82, hWH 10785
WDR41 WD repeat domain 41 MSTP048 55255
WDR43 WD repeat domain 43 NET12, UTP5 23160
WDR44 WD repeat domain 44 RAB11BP, RPH11, SYM-4 54521
WDR45 WD repeat domain 45 JM5, NBIA4, NBIA5, WDRX1, WIPI-4, 
WIPI4
11152
WDR45B WD repeat domain 45B NEDSBAS, WDR45L, WIPI-3, WIPI3 56270
WDR46 WD repeat domain 46 BING4, C6orf11, FP221, UTP7 9277
WDR47 WD repeat domain 47 22911
WDR48 WD repeat domain 48 P80, SPG60, UAF1 57599
WDR49 WD repeat domain 49 151790
WDR5 WD repeat domain 5 BIG-3, CFAP89, SWD3 11091
WDR53 WD repeat domain 53 348793
WDR54 WD repeat domain 54 84058
WDR55 WD repeat domain 55 54853
WDR59 WD repeat domain 59 CDW12, FP977, p90-120 79726
WDR5B WD repeat domain 5B 54554
WDR6 WD repeat domain 6 11180
WDR60 Dynein 2 intermediate chain 1 DYNC2I1, FAP163, DIC6, FAP163, SRPS6, 
SRTD8
55112
WDR61 WD repeat domain 61 REC14, SKI8 80349
WDR62 WD repeat domain 62 C19orf14, MCPH2 284403
WDR63 Dynein axonemal intermediate chain 3 DNAI3, DIC3, NYD-SP29 126820
WDR64 WD repeat domain 64 128025
WDR66 Cilia and flagella associated protein 251 CFAP251, CaM-IP4, SPGF33 144406
WDR7 WD repeat domain 7 TRAG 23335
WDR70 WD repeat domain 70 55100
WDR72 WD repeat domain 72 AI2A3 256764
WDR73 WD repeat domain 73 GAMOS, GAMOS1, HSPC264 84942
WDR74 WD repeat domain 74 Nsa1 54663
WDR75 WD repeat domain 75 NET16, UTP17 84128
WDR76 WD repeat domain 76 CDW14 79968
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WDR77 WD repeat domain 77 p44, MEP50, MEP-50, HKMT1069, 
Nbla10071, p44/Mep50
79084
WDR78 Dynein axonemal intermediate chain 4 DNAI4, DIC4 79819
WDR81 WD repeat domain 81 CAMRQ2, HYC3, PPP1R166, SORF-2 124997
WDR82 WD repeat domain 82 MST107, MSTP107, PRO2730, PRO34047, 
SWD2, TMEM113, WDR82A
80335
WDR83 WD repeat domain 83 MORG1 84292
WDR86 WD repeat domain 86 349136
WDR87 WD repeat domain 87 NYD-SP11 83889
WDR88 WD repeat domain 88 PQWD 126248
WDR89 WD repeat domain 89 C14orf150, MSTP050 112840
WDR90 WD repeat domain 90 C16orf15, C16orf16, C16orf17, C16orf18, 
C16orf19, POC16
197335
WDR91 WD repeat domain 91 HSPC049, SORF-1, SORF1 29062
WDR92 WD repeat domain 92 116143
WDR97 WD repeat domain 97 KIAA1875 340390
WDSUB1 WD repeat, sterile alpha motif and U-box domain containing 1 UBOX6, WDSAM1 151525
WDTC1 WD and tetratricopeptide repeats 1 ADP, DCAF9 23038
WIPI1 WD repeat domain, phosphoinositide interacting 1 ATG18, ATG18A, WIPI49 55062
WIPI2 WD repeat domain, phosphoinositide interacting 2 ATG18B, Atg21, CGI-50, IDDSSA, WIPI-2 26100
WRAP53 WD repeat containing antisense to TP53 DKCB3, TCAB1, WDR79 55135
WRAP73 WD repeat containing, antisense to TP73 WDR8 49856
WSB1 WD repeat and SOCS box containing 1 SWIP1, WSB-1 26118
WSB2 WD repeat and SOCS box containing 2 SBA2 55884
ZNF106 Zinc finger protein 106 SH3BP3, ZFP106, ZNF474 64397
WDR, WD40-repeat; NCBI, National Center for Biotechnology Information.
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Immune deficiency
   COPA Autoimmune interstitial lung, joint, and kidney disease 616414 AD
   CORO1A Immunodeficiency 615401 AR
   LYST Chediak-Higashi syndrome 214500 AR
   LRBA Immunodeficiency 614700 AR
   RFWD3 Fanconi anemia, complementation group W 617784 AR
   NBEAL2 Gray platelet syndrome 139090 AR
   DDB2 Xeroderma pigmentosum 278740 AR
Eye defect
   PRPF4 Retinitis pigmentosa 615922 AD
   POC1B Cone-rod dystrophy 615973 AR
   HPS5 Hermansky-Pudlak syndrome 614074 AR
   KIF21A Fibrosis of extraocular muscles, congenital 135700 AD
   WDR36 Glaucoma, open angle 609887 Multifactoral
   GNB3 Hypertension 145500 Multifactoral
Night blindness 617024 AR
Cancer predisposition
   NUP214 Encephalopathy, acute, infection-induced 618426 AR
Leukemia, acute myeloid, somatic 601626
Leukemia, T-cell acute lymphoblastic, somatic 613065
   PALB2 Breast cancer, susceptibility to 114480 Multifactoral
Pancreatic cancer, susceptibility to 613348
Fanconi anemia, complementation group N 610832
   GNB1 Leukemia, acute lymphoblastic, somatic 613065
Mental retardation 616973 AD
Skeletal defect
   EED Cohen-Gibson syndrome 617561 AD
   POC1A Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis 614813 AR
   TECPR2 Spastic paraplegia 49, autosomal recessive 615031 AR
Inflammation
   ATG16L1 Inflammatory bowel disease (Crohn disease) 611081 Not determined
   ARPC1B Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease 617718 AR
Othersa
   WRAP53 Dyskeratosis congenita 613988 AR
   NBAS Infantile liver failure syndrome 616483 AR
Short stature, optic nerve atrophy, and Pelger-Huet anomaly 614800 AR
   TLE6 Preimplantation embryonic lethality 616814 AR
   TRAF7 Cardiac, facial, and digital anomalies with developmental delay 618164 AD
   TBL1Y Deafness, Y-linked 400047 YL
   WDR72 Amelogenesis imperfecta, type IIA3 613211 AR
   PEX7 Peroxisome biogenesis disorder 614879 AR
Rhizomelic chondrodysplasia punctata, type 1 215100 AR
WDR, WD40-repeat; MIM, Mendelian Inheritance in Man; AD, autosomal dominant; AR, autosomal recessive; YL, Y-linked.
aIncluding multi-organ defects, liver failure, cardiovascular defects, and embryonic lethality.
Supplemental Table S2. List of WDR Proteins Related to Other Disorders
